Musculoskeletal Network Launches Special Coverage of FDA Biosimilars Policy Melodika.net (press release) Many newer "biological" drugs currently approved for these disorders, such as adalimumab (Humira) and rituximab (Rituxan), are identical to molecules created by the human immune system, except that these drugs are manufactured in cell cultures by ... |
